BRILINTA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Ticagrelor.
Product ID | 55154-9618_00b96008-1f1b-4704-992f-9ffb57d89f9d |
NDC | 55154-9618 |
Product Type | Human Prescription Drug |
Proprietary Name | BRILINTA |
Generic Name | Ticagrelor |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-08-05 |
Marketing Category | NDA / NDA |
Application Number | NDA022433 |
Labeler Name | Cardinal Health |
Substance Name | TICAGRELOR |
Active Ingredient Strength | 90 mg/1 |
Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Phenylalanine Hydroxylase Activators [MoA],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2011-08-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022433 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-08-05 |
Marketing Category | NDA |
Application Number | NDA022433 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-08-05 |
Ingredient | Strength |
---|---|
TICAGRELOR | 90 mg/1 |
SPL SET ID: | 4f9bd52a-99a7-4606-92b4-456a917aabef |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0186-0776 | BRILINTA | Ticagrelor |
0186-0777 | BRILINTA | Ticagrelor |
55154-9618 | BRILINTA | Ticagrelor |
69238-1134 | ticagrelor | ticagrelor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() BRILINTA 78457162 3040606 Live/Registered |
AstraZeneca AB 2004-07-27 |